登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Insulin R】

Insulin R信息

英文名称:Insulin receptor
中文名称:胰岛素受体
靶点别称:EC:2.7.10.1,EC 2.7.10,INSR,IR,Insulin receptor,CD220 Antigen,EC 2.7.10.1,CD220,HHF5,Receptor, Insulin
上市药物数量:89
临床药物数量:106
最高研发阶段:批准上市

Insulin R分子别名

INSR,Insulin receptor,IR,CD220

Insulin R分子背景

Insulin receptor (INSR) is also known as CD antigen CD220, which can be cleaved into the following 2 chains: Insulin receptor subunit alpha and Insulin receptor subunit beta. INSR is a tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains carry the insulin-binding regions, while the beta chains carry the kinase domain. Forms a hybrid receptor with IGF1R, the hybrid is a tetramer consisting of 1 alpha chain and 1 beta chain of INSR and 1 alpha chain and 1 beta chain of IGF1R. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short of INSR has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, INSR binds IGF1.

Insulin R上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

Insulin R临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定